Tumor-associated neutrophils (TAN) exhibit two phenotypes: the pro-tumor N2 phenotype, driven by TGF-β, and the anti-tumor phenotype (or N1), influenced by interferon-β (IFN-β) or TGF-β signaling suppression (36). This evidence concerns the gene TGFB1 and neoplasm.